Takrolimus Accord 0.1 % נורווגיה - נורבגית - Statens legemiddelverk

takrolimus accord 0.1 %

accord healthcare b.v. - takrolimusmonohydrat - salve - 0.1 %

Takrozem 0.1 % נורווגיה - נורבגית - Statens legemiddelverk

takrozem 0.1 %

pierre fabre dermatologie - takrolimus - salve - 0.1 %

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaksiner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.

Rybrevant האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

rybrevant

janssen-cilag international n.v.    - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Briviact 25 mg נורווגיה - נורבגית - Statens legemiddelverk

briviact 25 mg

2care4 aps - brivaracetam - tablett, filmdrasjert - 25 mg

Briviact 50 mg נורווגיה - נורבגית - Statens legemiddelverk

briviact 50 mg

2care4 aps - brivaracetam - tablett, filmdrasjert - 50 mg

Briviact 75 mg נורווגיה - נורבגית - Statens legemiddelverk

briviact 75 mg

2care4 aps - brivaracetam - tablett, filmdrasjert - 75 mg

Briviact 100 mg נורווגיה - נורבגית - Statens legemiddelverk

briviact 100 mg

2care4 aps - brivaracetam - tablett, filmdrasjert - 100 mg

Imprida HCT האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

imprida hct

novartis europharm ltd. - amlodipin, valsartan, hydroklortiazid - hypertensjon - angiotensin ii antagonister, vanlig, angiotensin ii antagonister, kombinasjoner - behandling av essensielle som erstatning terapi i voksen pasienter med blodtrykk er tilstrekkelig kontrollert på en kombinasjon av amlodipine, valsartan og hydroklortiazid (hct), tatt som tre single-komponent formuleringer eller som en dual-komponent og en single-komponent formulering.

Docetaxel Mylan האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

docetaxel mylan

mylan s.a.s. - docetaxel - head and neck neoplasms; carcinoma, non-small-cell lung; adenocarcinoma; prostatic neoplasms; breast neoplasms - antineoplastiske midler - behandling av brystkreft, spesielle former for lungekreft (ikke-småcellet lungekreft), prostatakreft, magekreft eller hode og hals kreft.